342 related articles for article (PubMed ID: 8387008)
1. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
2. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
Zhou Y; Sun YH; Han JS
Sheng Li Xue Bao; 1993 Jun; 45(3):255-61. PubMed ID: 8235725
[TBL] [Abstract][Full Text] [Related]
3. Increased release of immunoreactive CCK-8 by electroacupuncture and enhancement of electroacupuncture analgesia by CCK-B antagonist in rat spinal cord.
Zhou Y; Sun YH; Shen JM; Han JS
Neuropeptides; 1993 Mar; 24(3):139-44. PubMed ID: 8474632
[TBL] [Abstract][Full Text] [Related]
4. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
Urban MO; Smith DJ; Gebhart GF
J Pharmacol Exp Ther; 1996 Jul; 278(1):90-6. PubMed ID: 8764339
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
Stanfa LC; Dickenson AH
Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
[TBL] [Abstract][Full Text] [Related]
9. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
Dourish CT; O'Neill MF; Schaffer LW; Siegl PK; Iversen SD
J Pharmacol Exp Ther; 1990 Dec; 255(3):1158-65. PubMed ID: 2262899
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
11. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
12. Regulation by lithium of the antagonistic effect of cholecystokinin octapeptide on ohmefentanyl-induced antinociception.
Zhang LJ; Han NL; Han JS
Neuropharmacology; 1994 Jan; 33(1):123-6. PubMed ID: 8183436
[TBL] [Abstract][Full Text] [Related]
13. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
[TBL] [Abstract][Full Text] [Related]
14. Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections.
Goodchild CS; Nadeson R; Cohen E
Eur J Anaesthesiol; 2004 Mar; 21(3):179-85. PubMed ID: 15055889
[TBL] [Abstract][Full Text] [Related]
15. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
O'Neill MF; Dourish CT; Iversen SD
Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
[TBL] [Abstract][Full Text] [Related]
16. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
O'Neill MF; Dourish CT; Iversen SD
Neuropharmacology; 1989 Mar; 28(3):243-7. PubMed ID: 2725851
[TBL] [Abstract][Full Text] [Related]
17. Activation of spinal cholecystokinin and neurokinin-1 receptors is associated with the attenuation of intrathecal morphine analgesia following electroacupuncture stimulation in rats.
Fukazawa Y; Maeda T; Kiguchi N; Tohya K; Kimura M; Kishioka S
J Pharmacol Sci; 2007 Jun; 104(2):159-66. PubMed ID: 17558184
[TBL] [Abstract][Full Text] [Related]
18. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.
Higgins GA; Nguyen P; Sellers EM
Brain Res; 1992 Feb; 572(1-2):208-15. PubMed ID: 1611514
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
[TBL] [Abstract][Full Text] [Related]
20. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
Mei L; Han JS
Sci China B; 1993 Jul; 36(7):817-23. PubMed ID: 8216742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
